You are now leaving the Kedrion website. The information available in your chosen website may not be in compliance with EU legislation regulating the advertising of medicinal products for human use, nor do the opinions expressed necessarily reflect the Company’s positions or are endorsed by it.
NO
YES
  • Slide Image

    KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  • Slide Image

    KEEP LIFE FLOWING

    Kedrion’s plasma-derived therapies help people suffering from debilitating conditions like Hemophilia and Immune Deficiencies. We are privileged to provide this service and do so with a profound sense of responsibility.

  1. 1
  2. 2
  3. 3

News

CORPORATE

Kedrion grows in North America as it completes acquisition of Prometic

Launch is planned for the first ever FDA-approved treatment for patients suffering from Congenital Plasminogen Deficienc...

read more 

CORPORATE

Kedrion stronger in North America and further committed to rare diseases

Agreement with Canadian-based Liminal BioSciences signed on June 22nd

read more 

CORPORATE

Kedrion announces the appointment of a new CEO

Val Romberg from the USA, one of the most esteemed managers in the industry

read more 

2021
ANNUAL REPORT

PHARMACOVIGILANCE

MEDICAL & SCIENTIFIC INFORMATION

Kedrion hilite image